<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00769392</url>
  </required_header>
  <id_info>
    <org_study_id>2008-076</org_study_id>
    <nct_id>NCT00769392</nct_id>
  </id_info>
  <brief_title>Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection</brief_title>
  <official_title>Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lahey Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lahey Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare four currently used types of anesthesia used for
      intravitreal injection in order to evaluate the most effective method of anesthesia in
      reducing pain and discomfort associated with intravitreal injections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the last several years intravitreal injection of pharmacologic agents has become a
      common procedure in ophthalmology. Injected agents include steroid, antibiotics, and most
      recently anti-VEGF agents. There are many methods of preparing a patient for intravitreal
      injection. While there are guidelines for infection prophylaxis, there is currently no
      standard of care or consensus on which method of anesthesia is most effective in reducing
      pain and discomfort associated with intravitreal injections.

      Patients who have received prior injections and are scheduled to continue regular injections
      will be randomized to one of four types of anesthetic treatment for each of 4 treatment
      periods, so that each subject receives all four types of anesthesia over the course of the
      study, although the order will be different for each subject.

      Following each procedure, patients will fill out a questionnaire, grading the discomfort of
      both the anesthesia and the injection(on separate 0-10 scales).

      The anesthetic methods used will include: 1.) Drops of Proparacaine on the eye, 2.) Drops of
      Tetracaine on the eye, 3.) A cotton sponge (pledget) soaked with Lidocaine 4% placed over the
      conjunctiva and 4.)A subconjunctival injection with 2% Lidocaine.

      The subjects' number and type of visits, tests and treatments will be standard of care and
      will not be different due to the study. The total time for the treatment part of the study is
      the four injections or approximately 4 months and will be followed for up to 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Discomfort from anesthesia for intravitreal injection</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To examine the side effects and discomfort associated with the intravitreal injection</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Proparacaine Drops</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tetracaine Drops</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 4% soaked cotton sponge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 2% subconjunctival injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Proparacaine</intervention_name>
    <description>Drops of Proparacaine on the eye, administered as described in the package insert</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tetracaine</intervention_name>
    <description>Drops of Tetracaine on the eye, administered as described in the package insert</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>A cotton sponge(pledget)soaked with Lidocaine 4% placed over the conjunctiva</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>A subconjunctival injection of Lidocaine 2%</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female &gt; 40 years of age

          -  Diagnosis of age-related macular degeneration

          -  History of at least 1 intravitreal injection in the past in either eye

          -  Written informed consent has been obtained

        Exclusion Criteria:

          -  Known allergy or sensitivity to the study medications(s), it's components, or other
             agents required for the study procedures(e.g. Povidone iodine)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory R. Blaha, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lahey Clinic, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lahey Clinic Arlington</name>
      <address>
        <city>Arlington</city>
        <state>Massachusetts</state>
        <zip>02474</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic, Inc.</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic Northshore</name>
      <address>
        <city>Peabody</city>
        <state>Massachusetts</state>
        <zip>01960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kaderli B, Avci R. Comparison of topical and subconjunctival anesthesia in intravitreal injection administrations. Eur J Ophthalmol. 2006 Sep-Oct;16(5):718-21.</citation>
    <PMID>17061223</PMID>
  </reference>
  <reference>
    <citation>Landry DA. Topical anesthetic pledgett system (TAPS) for intravitreal injection preparation. Insight. 2007 Oct-Dec;32(4):20.</citation>
    <PMID>18306942</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2008</study_first_submitted>
  <study_first_submitted_qc>October 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2008</study_first_posted>
  <last_update_submitted>May 9, 2012</last_update_submitted>
  <last_update_submitted_qc>May 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Macular Degeneration</keyword>
  <keyword>Intravitreal injections</keyword>
  <keyword>Eye anesthesia-Topical/subconjunctival</keyword>
  <keyword>Eye-surgical procedures</keyword>
  <keyword>Ophthalmologic anesthesia methods</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
    <mesh_term>Proxymetacaine</mesh_term>
    <mesh_term>Propoxycaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 26, 2014</submitted>
    <returned>April 24, 2014</returned>
    <submitted>March 15, 2018</submitted>
    <returned>April 16, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

